Silvia Valtorta

I graduated in Medical Biotechnology from the University of Milano-Bicocca in 2007 and obtained my PhD in Molecular Medicine from the University of Milano in 2010. From 2011 to 2021, I worked as a Postdoctoral Associate in the Laboratory of Preclinical Imaging, under the direction of Prof. Moresco. In 2014, I was awarded a CNR short-term mobility grant, which enabled me to spend a month at the European Institute for Molecular Imaging (EIMI) in Münster, Germany, where I studied translocator protein (TSPO) PET radiotracers in glioblastoma mouse models. Since 2022, I have been a Researcher at the CNR.

My research interests are aimed to the development of novel diagnostic and prognostic biomarkers for glioma, as well as biomarkers for treatment response, utilizing multimodal imaging techniques (PET/SPECT/MRI, Optical Imaging). Specifically, my research activities encompass:

a) Development of novel radiopharmaceuticals for brain molecular imaging.
b) Development of new imaging biomarkers in murine and cellular models of brain tumors.
c) Validation of metabolic modulators as potential therapeutic agents for brain tumors.

Furthermore, a portion of my research is dedicated to the establishment and optimization of SPECT procedures, facilitated by the acquisition of a SPECT system in collaboration with physicists and engineers.

POTENTIAL RESEARCH ACTIVITIES DURING THE PHD PROGRAM

Multimodal imaging approaches for characterizing the molecular features and the therapy response of brain tumor

OTHER DETAILS

Collaborations: Main collaboration for Imaging procedures and preclinical models:  IRCCS San Raffaele Hospital, University of Milano-Bicocca, Tecnomed Foundation Web sites: https://www.ibsbc.cnr.it/